nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A5—Dactinomycin—sarcoma	0.399	0.561	CbGbCtD
Ipratropium bromide—CYP3A4—Thiotepa—sarcoma	0.126	0.178	CbGbCtD
Ipratropium bromide—CYP3A4—Mitoxantrone—sarcoma	0.0542	0.0763	CbGbCtD
Ipratropium bromide—CYP3A4—Vincristine—sarcoma	0.0373	0.0525	CbGbCtD
Ipratropium bromide—CYP2D6—Doxorubicin—sarcoma	0.0367	0.0516	CbGbCtD
Ipratropium bromide—CYP3A4—Etoposide—sarcoma	0.0342	0.0481	CbGbCtD
Ipratropium bromide—CYP3A4—Doxorubicin—sarcoma	0.0233	0.0328	CbGbCtD
Ipratropium bromide—CHRM3—muscle of abdomen—sarcoma	0.00634	0.237	CbGeAlD
Ipratropium bromide—SLC22A4—larynx—sarcoma	0.0053	0.198	CbGeAlD
Ipratropium bromide—SLC22A4—mammary gland—sarcoma	0.00172	0.0641	CbGeAlD
Ipratropium bromide—CHRM5—skin of body—sarcoma	0.00128	0.0479	CbGeAlD
Ipratropium bromide—SLC22A4—myometrium—sarcoma	0.00122	0.0455	CbGeAlD
Ipratropium bromide—SLC22A5—mammary gland—sarcoma	0.00114	0.0424	CbGeAlD
Ipratropium bromide—SLC22A4—seminal vesicle—sarcoma	0.0011	0.0411	CbGeAlD
Ipratropium bromide—SLC22A5—myometrium—sarcoma	0.000806	0.0301	CbGeAlD
Ipratropium bromide—Anaphylactic shock—Mitoxantrone—sarcoma	0.00077	0.00293	CcSEcCtD
Ipratropium bromide—Oedema—Mitoxantrone—sarcoma	0.00077	0.00293	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Thiotepa—sarcoma	0.000769	0.00293	CcSEcCtD
Ipratropium bromide—Fatigue—Thiotepa—sarcoma	0.000768	0.00292	CcSEcCtD
Ipratropium bromide—Dysgeusia—Etoposide—sarcoma	0.000768	0.00292	CcSEcCtD
Ipratropium bromide—Infection—Mitoxantrone—sarcoma	0.000765	0.00291	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Vincristine—sarcoma	0.000764	0.00291	CcSEcCtD
Ipratropium bromide—Fatigue—Dactinomycin—sarcoma	0.000763	0.0029	CcSEcCtD
Ipratropium bromide—Constipation—Thiotepa—sarcoma	0.000762	0.0029	CcSEcCtD
Ipratropium bromide—Pain—Thiotepa—sarcoma	0.000762	0.0029	CcSEcCtD
Ipratropium bromide—Back pain—Etoposide—sarcoma	0.000759	0.00289	CcSEcCtD
Ipratropium bromide—Pain—Dactinomycin—sarcoma	0.000756	0.00288	CcSEcCtD
Ipratropium bromide—Tachycardia—Mitoxantrone—sarcoma	0.000751	0.00286	CcSEcCtD
Ipratropium bromide—Eye pain—Doxorubicin—sarcoma	0.000748	0.00285	CcSEcCtD
Ipratropium bromide—Skin disorder—Mitoxantrone—sarcoma	0.000748	0.00284	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Mitoxantrone—sarcoma	0.000744	0.00283	CcSEcCtD
Ipratropium bromide—Hypotension—Vincristine—sarcoma	0.000738	0.00281	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Thiotepa—sarcoma	0.000729	0.00277	CcSEcCtD
Ipratropium bromide—SLC22A5—seminal vesicle—sarcoma	0.000728	0.0272	CbGeAlD
Ipratropium bromide—CHRM3—smooth muscle tissue—sarcoma	0.000727	0.0272	CbGeAlD
Ipratropium bromide—Gastrointestinal pain—Dactinomycin—sarcoma	0.000723	0.00275	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Vincristine—sarcoma	0.00072	0.00274	CcSEcCtD
Ipratropium bromide—Hypotension—Mitoxantrone—sarcoma	0.000719	0.00274	CcSEcCtD
Ipratropium bromide—Insomnia—Vincristine—sarcoma	0.000715	0.00272	CcSEcCtD
Ipratropium bromide—Paraesthesia—Vincristine—sarcoma	0.00071	0.0027	CcSEcCtD
Ipratropium bromide—Urticaria—Thiotepa—sarcoma	0.000708	0.00269	CcSEcCtD
Ipratropium bromide—Abdominal pain—Thiotepa—sarcoma	0.000704	0.00268	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000701	0.00267	CcSEcCtD
Ipratropium bromide—Abdominal pain—Dactinomycin—sarcoma	0.000699	0.00266	CcSEcCtD
Ipratropium bromide—SLC22A4—tendon—sarcoma	0.000692	0.0258	CbGeAlD
Ipratropium bromide—Paraesthesia—Mitoxantrone—sarcoma	0.000691	0.00263	CcSEcCtD
Ipratropium bromide—Dyspnoea—Mitoxantrone—sarcoma	0.000686	0.00261	CcSEcCtD
Ipratropium bromide—Cough—Etoposide—sarcoma	0.000684	0.0026	CcSEcCtD
Ipratropium bromide—Somnolence—Mitoxantrone—sarcoma	0.000684	0.0026	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Vincristine—sarcoma	0.000682	0.0026	CcSEcCtD
Ipratropium bromide—Fatigue—Vincristine—sarcoma	0.000681	0.00259	CcSEcCtD
Ipratropium bromide—Dyspepsia—Mitoxantrone—sarcoma	0.000677	0.00258	CcSEcCtD
Ipratropium bromide—Hypertension—Etoposide—sarcoma	0.000677	0.00258	CcSEcCtD
Ipratropium bromide—Constipation—Vincristine—sarcoma	0.000676	0.00257	CcSEcCtD
Ipratropium bromide—Pain—Vincristine—sarcoma	0.000676	0.00257	CcSEcCtD
Ipratropium bromide—SLC22A4—bone marrow—sarcoma	0.00067	0.025	CbGeAlD
Ipratropium bromide—Chest pain—Etoposide—sarcoma	0.000668	0.00254	CcSEcCtD
Ipratropium bromide—Fatigue—Mitoxantrone—sarcoma	0.000664	0.00252	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000663	0.00252	CcSEcCtD
Ipratropium bromide—Constipation—Mitoxantrone—sarcoma	0.000658	0.0025	CcSEcCtD
Ipratropium bromide—Pain—Mitoxantrone—sarcoma	0.000658	0.0025	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Thiotepa—sarcoma	0.000657	0.0025	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Dactinomycin—sarcoma	0.000652	0.00248	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Vincristine—sarcoma	0.000646	0.00246	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Etoposide—sarcoma	0.00064	0.00244	CcSEcCtD
Ipratropium bromide—Asthenia—Thiotepa—sarcoma	0.000639	0.00243	CcSEcCtD
Ipratropium bromide—Infection—Etoposide—sarcoma	0.000636	0.00242	CcSEcCtD
Ipratropium bromide—Asthenia—Dactinomycin—sarcoma	0.000635	0.00241	CcSEcCtD
Ipratropium bromide—Influenza—Epirubicin—sarcoma	0.000631	0.0024	CcSEcCtD
Ipratropium bromide—Dysphagia—Epirubicin—sarcoma	0.000631	0.0024	CcSEcCtD
Ipratropium bromide—Asthma—Epirubicin—sarcoma	0.000631	0.0024	CcSEcCtD
Ipratropium bromide—Pruritus—Thiotepa—sarcoma	0.000631	0.0024	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000629	0.00239	CcSEcCtD
Ipratropium bromide—Tachycardia—Etoposide—sarcoma	0.000625	0.00238	CcSEcCtD
Ipratropium bromide—Abdominal pain—Vincristine—sarcoma	0.000625	0.00238	CcSEcCtD
Ipratropium bromide—Skin disorder—Etoposide—sarcoma	0.000622	0.00237	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Etoposide—sarcoma	0.000619	0.00235	CcSEcCtD
Ipratropium bromide—Urticaria—Mitoxantrone—sarcoma	0.000611	0.00233	CcSEcCtD
Ipratropium bromide—Diarrhoea—Thiotepa—sarcoma	0.00061	0.00232	CcSEcCtD
Ipratropium bromide—Abdominal pain—Mitoxantrone—sarcoma	0.000608	0.00231	CcSEcCtD
Ipratropium bromide—Bronchitis—Epirubicin—sarcoma	0.000607	0.00231	CcSEcCtD
Ipratropium bromide—Diarrhoea—Dactinomycin—sarcoma	0.000605	0.0023	CcSEcCtD
Ipratropium bromide—SLC22A5—skin of body—sarcoma	0.000602	0.0225	CbGeAlD
Ipratropium bromide—Hypotension—Etoposide—sarcoma	0.000598	0.00228	CcSEcCtD
Ipratropium bromide—Dysuria—Epirubicin—sarcoma	0.00059	0.00224	CcSEcCtD
Ipratropium bromide—Dizziness—Thiotepa—sarcoma	0.000589	0.00224	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Epirubicin—sarcoma	0.000586	0.00223	CcSEcCtD
Ipratropium bromide—Influenza—Doxorubicin—sarcoma	0.000584	0.00222	CcSEcCtD
Ipratropium bromide—Asthma—Doxorubicin—sarcoma	0.000584	0.00222	CcSEcCtD
Ipratropium bromide—Dysphagia—Doxorubicin—sarcoma	0.000584	0.00222	CcSEcCtD
Ipratropium bromide—Pollakiuria—Epirubicin—sarcoma	0.000583	0.00222	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Vincristine—sarcoma	0.000582	0.00222	CcSEcCtD
Ipratropium bromide—Paraesthesia—Etoposide—sarcoma	0.000575	0.00219	CcSEcCtD
Ipratropium bromide—Dyspnoea—Etoposide—sarcoma	0.000571	0.00217	CcSEcCtD
Ipratropium bromide—Somnolence—Etoposide—sarcoma	0.000569	0.00217	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Mitoxantrone—sarcoma	0.000567	0.00216	CcSEcCtD
Ipratropium bromide—Asthenia—Vincristine—sarcoma	0.000567	0.00216	CcSEcCtD
Ipratropium bromide—Vomiting—Thiotepa—sarcoma	0.000567	0.00216	CcSEcCtD
Ipratropium bromide—Vomiting—Dactinomycin—sarcoma	0.000562	0.00214	CcSEcCtD
Ipratropium bromide—Rash—Thiotepa—sarcoma	0.000562	0.00214	CcSEcCtD
Ipratropium bromide—Bronchitis—Doxorubicin—sarcoma	0.000562	0.00214	CcSEcCtD
Ipratropium bromide—Dermatitis—Thiotepa—sarcoma	0.000561	0.00214	CcSEcCtD
Ipratropium bromide—Headache—Thiotepa—sarcoma	0.000558	0.00212	CcSEcCtD
Ipratropium bromide—Rash—Dactinomycin—sarcoma	0.000558	0.00212	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Etoposide—sarcoma	0.000553	0.0021	CcSEcCtD
Ipratropium bromide—Asthenia—Mitoxantrone—sarcoma	0.000552	0.0021	CcSEcCtD
Ipratropium bromide—Fatigue—Etoposide—sarcoma	0.000552	0.0021	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Epirubicin—sarcoma	0.000552	0.0021	CcSEcCtD
Ipratropium bromide—Stomatitis—Epirubicin—sarcoma	0.000548	0.00209	CcSEcCtD
Ipratropium bromide—Pain—Etoposide—sarcoma	0.000547	0.00208	CcSEcCtD
Ipratropium bromide—Constipation—Etoposide—sarcoma	0.000547	0.00208	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Epirubicin—sarcoma	0.000547	0.00208	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Epirubicin—sarcoma	0.000547	0.00208	CcSEcCtD
Ipratropium bromide—Dysuria—Doxorubicin—sarcoma	0.000546	0.00208	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000543	0.00206	CcSEcCtD
Ipratropium bromide—Diarrhoea—Vincristine—sarcoma	0.000541	0.00206	CcSEcCtD
Ipratropium bromide—Sweating—Epirubicin—sarcoma	0.000539	0.00205	CcSEcCtD
Ipratropium bromide—Pollakiuria—Doxorubicin—sarcoma	0.000539	0.00205	CcSEcCtD
Ipratropium bromide—Epistaxis—Epirubicin—sarcoma	0.000531	0.00202	CcSEcCtD
Ipratropium bromide—Nausea—Thiotepa—sarcoma	0.000529	0.00201	CcSEcCtD
Ipratropium bromide—Sinusitis—Epirubicin—sarcoma	0.000528	0.00201	CcSEcCtD
Ipratropium bromide—Diarrhoea—Mitoxantrone—sarcoma	0.000527	0.002	CcSEcCtD
Ipratropium bromide—SLC22A5—cardiac atrium—sarcoma	0.000526	0.0196	CbGeAlD
Ipratropium bromide—Nausea—Dactinomycin—sarcoma	0.000525	0.002	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Etoposide—sarcoma	0.000523	0.00199	CcSEcCtD
Ipratropium bromide—Dizziness—Vincristine—sarcoma	0.000523	0.00199	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Doxorubicin—sarcoma	0.00051	0.00194	CcSEcCtD
Ipratropium bromide—Urticaria—Etoposide—sarcoma	0.000509	0.00193	CcSEcCtD
Ipratropium bromide—Haemoglobin—Epirubicin—sarcoma	0.000508	0.00193	CcSEcCtD
Ipratropium bromide—Stomatitis—Doxorubicin—sarcoma	0.000507	0.00193	CcSEcCtD
Ipratropium bromide—Rhinitis—Epirubicin—sarcoma	0.000506	0.00193	CcSEcCtD
Ipratropium bromide—Abdominal pain—Etoposide—sarcoma	0.000506	0.00193	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Doxorubicin—sarcoma	0.000506	0.00193	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Doxorubicin—sarcoma	0.000506	0.00193	CcSEcCtD
Ipratropium bromide—Haemorrhage—Epirubicin—sarcoma	0.000505	0.00192	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Epirubicin—sarcoma	0.000503	0.00191	CcSEcCtD
Ipratropium bromide—Vomiting—Vincristine—sarcoma	0.000502	0.00191	CcSEcCtD
Ipratropium bromide—Pharyngitis—Epirubicin—sarcoma	0.000501	0.00191	CcSEcCtD
Ipratropium bromide—Sweating—Doxorubicin—sarcoma	0.000499	0.0019	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Epirubicin—sarcoma	0.000499	0.0019	CcSEcCtD
Ipratropium bromide—Rash—Vincristine—sarcoma	0.000498	0.0019	CcSEcCtD
Ipratropium bromide—Dermatitis—Vincristine—sarcoma	0.000498	0.00189	CcSEcCtD
Ipratropium bromide—Urethral disorder—Epirubicin—sarcoma	0.000495	0.00188	CcSEcCtD
Ipratropium bromide—Headache—Vincristine—sarcoma	0.000495	0.00188	CcSEcCtD
Ipratropium bromide—Epistaxis—Doxorubicin—sarcoma	0.000491	0.00187	CcSEcCtD
Ipratropium bromide—Vomiting—Mitoxantrone—sarcoma	0.000489	0.00186	CcSEcCtD
Ipratropium bromide—Sinusitis—Doxorubicin—sarcoma	0.000488	0.00186	CcSEcCtD
Ipratropium bromide—Visual impairment—Epirubicin—sarcoma	0.000487	0.00185	CcSEcCtD
Ipratropium bromide—Rash—Mitoxantrone—sarcoma	0.000485	0.00185	CcSEcCtD
Ipratropium bromide—Dermatitis—Mitoxantrone—sarcoma	0.000485	0.00184	CcSEcCtD
Ipratropium bromide—Headache—Mitoxantrone—sarcoma	0.000482	0.00183	CcSEcCtD
Ipratropium bromide—Eye disorder—Epirubicin—sarcoma	0.000472	0.0018	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Etoposide—sarcoma	0.000472	0.00179	CcSEcCtD
Ipratropium bromide—Tinnitus—Epirubicin—sarcoma	0.000471	0.00179	CcSEcCtD
Ipratropium bromide—Haemoglobin—Doxorubicin—sarcoma	0.00047	0.00179	CcSEcCtD
Ipratropium bromide—Nausea—Vincristine—sarcoma	0.000469	0.00179	CcSEcCtD
Ipratropium bromide—Flushing—Epirubicin—sarcoma	0.000469	0.00178	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Epirubicin—sarcoma	0.000469	0.00178	CcSEcCtD
Ipratropium bromide—Rhinitis—Doxorubicin—sarcoma	0.000469	0.00178	CcSEcCtD
Ipratropium bromide—Haemorrhage—Doxorubicin—sarcoma	0.000467	0.00178	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Doxorubicin—sarcoma	0.000465	0.00177	CcSEcCtD
Ipratropium bromide—Pharyngitis—Doxorubicin—sarcoma	0.000464	0.00176	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Doxorubicin—sarcoma	0.000462	0.00176	CcSEcCtD
Ipratropium bromide—Asthenia—Etoposide—sarcoma	0.000459	0.00175	CcSEcCtD
Ipratropium bromide—Urethral disorder—Doxorubicin—sarcoma	0.000458	0.00174	CcSEcCtD
Ipratropium bromide—SLC22A5—tendon—sarcoma	0.000458	0.0171	CbGeAlD
Ipratropium bromide—Nausea—Mitoxantrone—sarcoma	0.000457	0.00174	CcSEcCtD
Ipratropium bromide—Immune system disorder—Epirubicin—sarcoma	0.000456	0.00174	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Epirubicin—sarcoma	0.000455	0.00173	CcSEcCtD
Ipratropium bromide—CYP3A4—hematopoietic system—sarcoma	0.000454	0.0169	CbGeAlD
Ipratropium bromide—Pruritus—Etoposide—sarcoma	0.000453	0.00172	CcSEcCtD
Ipratropium bromide—CHRM3—testis—sarcoma	0.000453	0.0169	CbGeAlD
Ipratropium bromide—Visual impairment—Doxorubicin—sarcoma	0.00045	0.00171	CcSEcCtD
Ipratropium bromide—CYP2D6—hematopoietic system—sarcoma	0.000447	0.0167	CbGeAlD
Ipratropium bromide—Diarrhoea—Etoposide—sarcoma	0.000438	0.00167	CcSEcCtD
Ipratropium bromide—Eye disorder—Doxorubicin—sarcoma	0.000437	0.00166	CcSEcCtD
Ipratropium bromide—Tinnitus—Doxorubicin—sarcoma	0.000436	0.00166	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Doxorubicin—sarcoma	0.000434	0.00165	CcSEcCtD
Ipratropium bromide—Flushing—Doxorubicin—sarcoma	0.000434	0.00165	CcSEcCtD
Ipratropium bromide—Flatulence—Epirubicin—sarcoma	0.000433	0.00165	CcSEcCtD
Ipratropium bromide—Tension—Epirubicin—sarcoma	0.000431	0.00164	CcSEcCtD
Ipratropium bromide—Dysgeusia—Epirubicin—sarcoma	0.000431	0.00164	CcSEcCtD
Ipratropium bromide—Nervousness—Epirubicin—sarcoma	0.000427	0.00162	CcSEcCtD
Ipratropium bromide—Back pain—Epirubicin—sarcoma	0.000425	0.00162	CcSEcCtD
Ipratropium bromide—Dizziness—Etoposide—sarcoma	0.000423	0.00161	CcSEcCtD
Ipratropium bromide—Immune system disorder—Doxorubicin—sarcoma	0.000422	0.00161	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Doxorubicin—sarcoma	0.000421	0.0016	CcSEcCtD
Ipratropium bromide—SLC22A4—lymph node—sarcoma	0.000415	0.0155	CbGeAlD
Ipratropium bromide—Vision blurred—Epirubicin—sarcoma	0.000414	0.00158	CcSEcCtD
Ipratropium bromide—Vomiting—Etoposide—sarcoma	0.000407	0.00155	CcSEcCtD
Ipratropium bromide—Rash—Etoposide—sarcoma	0.000404	0.00154	CcSEcCtD
Ipratropium bromide—Dermatitis—Etoposide—sarcoma	0.000403	0.00153	CcSEcCtD
Ipratropium bromide—Headache—Etoposide—sarcoma	0.000401	0.00153	CcSEcCtD
Ipratropium bromide—Flatulence—Doxorubicin—sarcoma	0.000401	0.00153	CcSEcCtD
Ipratropium bromide—Tension—Doxorubicin—sarcoma	0.000399	0.00152	CcSEcCtD
Ipratropium bromide—Dysgeusia—Doxorubicin—sarcoma	0.000398	0.00152	CcSEcCtD
Ipratropium bromide—Nervousness—Doxorubicin—sarcoma	0.000395	0.0015	CcSEcCtD
Ipratropium bromide—Back pain—Doxorubicin—sarcoma	0.000394	0.0015	CcSEcCtD
Ipratropium bromide—Palpitations—Epirubicin—sarcoma	0.000389	0.00148	CcSEcCtD
Ipratropium bromide—Cough—Epirubicin—sarcoma	0.000384	0.00146	CcSEcCtD
Ipratropium bromide—Vision blurred—Doxorubicin—sarcoma	0.000383	0.00146	CcSEcCtD
Ipratropium bromide—Nausea—Etoposide—sarcoma	0.00038	0.00145	CcSEcCtD
Ipratropium bromide—Hypertension—Epirubicin—sarcoma	0.00038	0.00144	CcSEcCtD
Ipratropium bromide—SLC22A5—testis—sarcoma	0.000379	0.0142	CbGeAlD
Ipratropium bromide—Chest pain—Epirubicin—sarcoma	0.000374	0.00142	CcSEcCtD
Ipratropium bromide—Myalgia—Epirubicin—sarcoma	0.000374	0.00142	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000372	0.00141	CcSEcCtD
Ipratropium bromide—Dry mouth—Epirubicin—sarcoma	0.000366	0.00139	CcSEcCtD
Ipratropium bromide—Palpitations—Doxorubicin—sarcoma	0.00036	0.00137	CcSEcCtD
Ipratropium bromide—Oedema—Epirubicin—sarcoma	0.000359	0.00137	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Epirubicin—sarcoma	0.000359	0.00137	CcSEcCtD
Ipratropium bromide—SLC22A5—liver—sarcoma	0.000359	0.0134	CbGeAlD
Ipratropium bromide—Infection—Epirubicin—sarcoma	0.000356	0.00136	CcSEcCtD
Ipratropium bromide—Cough—Doxorubicin—sarcoma	0.000355	0.00135	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Epirubicin—sarcoma	0.000352	0.00134	CcSEcCtD
Ipratropium bromide—Hypertension—Doxorubicin—sarcoma	0.000351	0.00134	CcSEcCtD
Ipratropium bromide—Tachycardia—Epirubicin—sarcoma	0.00035	0.00133	CcSEcCtD
Ipratropium bromide—Skin disorder—Epirubicin—sarcoma	0.000349	0.00133	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Epirubicin—sarcoma	0.000347	0.00132	CcSEcCtD
Ipratropium bromide—Chest pain—Doxorubicin—sarcoma	0.000346	0.00132	CcSEcCtD
Ipratropium bromide—Myalgia—Doxorubicin—sarcoma	0.000346	0.00132	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000344	0.00131	CcSEcCtD
Ipratropium bromide—Dry mouth—Doxorubicin—sarcoma	0.000339	0.00129	CcSEcCtD
Ipratropium bromide—Hypotension—Epirubicin—sarcoma	0.000335	0.00128	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Doxorubicin—sarcoma	0.000332	0.00126	CcSEcCtD
Ipratropium bromide—Oedema—Doxorubicin—sarcoma	0.000332	0.00126	CcSEcCtD
Ipratropium bromide—Infection—Doxorubicin—sarcoma	0.00033	0.00125	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000327	0.00124	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Doxorubicin—sarcoma	0.000326	0.00124	CcSEcCtD
Ipratropium bromide—Insomnia—Epirubicin—sarcoma	0.000325	0.00123	CcSEcCtD
Ipratropium bromide—Tachycardia—Doxorubicin—sarcoma	0.000324	0.00123	CcSEcCtD
Ipratropium bromide—Skin disorder—Doxorubicin—sarcoma	0.000323	0.00123	CcSEcCtD
Ipratropium bromide—Paraesthesia—Epirubicin—sarcoma	0.000322	0.00123	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Doxorubicin—sarcoma	0.000321	0.00122	CcSEcCtD
Ipratropium bromide—Dyspnoea—Epirubicin—sarcoma	0.00032	0.00122	CcSEcCtD
Ipratropium bromide—Somnolence—Epirubicin—sarcoma	0.000319	0.00121	CcSEcCtD
Ipratropium bromide—Dyspepsia—Epirubicin—sarcoma	0.000316	0.0012	CcSEcCtD
Ipratropium bromide—Hypotension—Doxorubicin—sarcoma	0.00031	0.00118	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Epirubicin—sarcoma	0.00031	0.00118	CcSEcCtD
Ipratropium bromide—Fatigue—Epirubicin—sarcoma	0.000309	0.00118	CcSEcCtD
Ipratropium bromide—Constipation—Epirubicin—sarcoma	0.000307	0.00117	CcSEcCtD
Ipratropium bromide—Pain—Epirubicin—sarcoma	0.000307	0.00117	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000302	0.00115	CcSEcCtD
Ipratropium bromide—Insomnia—Doxorubicin—sarcoma	0.0003	0.00114	CcSEcCtD
Ipratropium bromide—Paraesthesia—Doxorubicin—sarcoma	0.000298	0.00113	CcSEcCtD
Ipratropium bromide—Dyspnoea—Doxorubicin—sarcoma	0.000296	0.00113	CcSEcCtD
Ipratropium bromide—Somnolence—Doxorubicin—sarcoma	0.000295	0.00112	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Epirubicin—sarcoma	0.000293	0.00112	CcSEcCtD
Ipratropium bromide—Dyspepsia—Doxorubicin—sarcoma	0.000292	0.00111	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000287	0.00109	CcSEcCtD
Ipratropium bromide—Fatigue—Doxorubicin—sarcoma	0.000286	0.00109	CcSEcCtD
Ipratropium bromide—Urticaria—Epirubicin—sarcoma	0.000285	0.00108	CcSEcCtD
Ipratropium bromide—Constipation—Doxorubicin—sarcoma	0.000284	0.00108	CcSEcCtD
Ipratropium bromide—Pain—Doxorubicin—sarcoma	0.000284	0.00108	CcSEcCtD
Ipratropium bromide—Abdominal pain—Epirubicin—sarcoma	0.000284	0.00108	CcSEcCtD
Ipratropium bromide—SLC22A5—lymph node—sarcoma	0.000275	0.0103	CbGeAlD
Ipratropium bromide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000272	0.00103	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Epirubicin—sarcoma	0.000264	0.00101	CcSEcCtD
Ipratropium bromide—Urticaria—Doxorubicin—sarcoma	0.000264	0.001	CcSEcCtD
Ipratropium bromide—Abdominal pain—Doxorubicin—sarcoma	0.000262	0.000999	CcSEcCtD
Ipratropium bromide—Asthenia—Epirubicin—sarcoma	0.000257	0.000979	CcSEcCtD
Ipratropium bromide—Pruritus—Epirubicin—sarcoma	0.000254	0.000966	CcSEcCtD
Ipratropium bromide—Diarrhoea—Epirubicin—sarcoma	0.000246	0.000934	CcSEcCtD
Ipratropium bromide—CYP2D6—testis—sarcoma	0.000245	0.00913	CbGeAlD
Ipratropium bromide—Hypersensitivity—Doxorubicin—sarcoma	0.000245	0.000931	CcSEcCtD
Ipratropium bromide—Asthenia—Doxorubicin—sarcoma	0.000238	0.000906	CcSEcCtD
Ipratropium bromide—Dizziness—Epirubicin—sarcoma	0.000237	0.000903	CcSEcCtD
Ipratropium bromide—CYP3A4—liver—sarcoma	0.000235	0.00878	CbGeAlD
Ipratropium bromide—Pruritus—Doxorubicin—sarcoma	0.000235	0.000894	CcSEcCtD
Ipratropium bromide—CYP2D6—liver—sarcoma	0.000231	0.00864	CbGeAlD
Ipratropium bromide—Vomiting—Epirubicin—sarcoma	0.000228	0.000868	CcSEcCtD
Ipratropium bromide—Diarrhoea—Doxorubicin—sarcoma	0.000227	0.000864	CcSEcCtD
Ipratropium bromide—Rash—Epirubicin—sarcoma	0.000226	0.000861	CcSEcCtD
Ipratropium bromide—Dermatitis—Epirubicin—sarcoma	0.000226	0.00086	CcSEcCtD
Ipratropium bromide—Headache—Epirubicin—sarcoma	0.000225	0.000855	CcSEcCtD
Ipratropium bromide—Dizziness—Doxorubicin—sarcoma	0.00022	0.000835	CcSEcCtD
Ipratropium bromide—Nausea—Epirubicin—sarcoma	0.000213	0.000811	CcSEcCtD
Ipratropium bromide—Vomiting—Doxorubicin—sarcoma	0.000211	0.000803	CcSEcCtD
Ipratropium bromide—Rash—Doxorubicin—sarcoma	0.000209	0.000796	CcSEcCtD
Ipratropium bromide—Dermatitis—Doxorubicin—sarcoma	0.000209	0.000796	CcSEcCtD
Ipratropium bromide—Headache—Doxorubicin—sarcoma	0.000208	0.000791	CcSEcCtD
Ipratropium bromide—Nausea—Doxorubicin—sarcoma	0.000197	0.00075	CcSEcCtD
